Precision Med TRI-CON

XiFin’s Clarisa Blattner Speaking at Precision
Med TRI-CON

XiFin is proud to participate in the 32nd Annual Precision Med TRI-CON from March 11-13, 2025, in San Diego, California. This premier event brings together thousands of diagnostics, market access, and reimbursement innovators to discuss the latest advancements in diagnostics, precision medicine, biomarkers, genomic medicine, and artificial intelligence.

XiFin’s own Clarisa Blattner, Senior Director of Revenue & Payor Optimization, will participate as a panelist in the “Payors and Labs in Transition” panel discussion on March 12 from 2:35–3:35 PM PT. She will share insights on how specialty labs and payors are adapting to evolving reimbursement policies and new genomic technologies. With over 20 years of healthcare experience, including leadership roles at US Labs, Clarient, and MDxHealth, Clarisa brings extensive expertise in revenue cycle management and reimbursement.

Featured Sessions

Payors and Labs in Transition

March 12, 2025 | 2:35 – 3:35 PM PT

Clarisa Blattner

Sr. Director, Revenue and Payor Optimization
XiFin, Inc.

Specialty laboratories and payors are adjusting to changing reimbursement policies as new genomic technologies quickly become available in clinical settings. National experts will explore strategies for both Medicare and commercial payors, as well as the effects of regulatory changes. Panelists will offer practical advice on how to align lab operations with payor priorities and prepare for upcoming challenges and opportunities.